Review decisions

Showing 50 results of 292 total
Summary Safety Review - Domperidone - Assessing the Potential Risks of Serious Ventricular Arrhythmias, QT Interval Prolongation and Sudden Cardiac Death
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00277
Issued / Original Publication Date: 2021-12-30
Updated Date: 2022-12-08
Summary Safety Review - Amoxicillin-containing Products - Assessing the Potential Risk of Aseptic Meningitis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00276
Issued / Original Publication Date: 2021-12-10
Summary Safety Review - Aimovig (erenumab) - Assessing the Potential Risks of Non-Fatal Stroke, Non-Fatal Heart Attack and Cardiovascular Death
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00275
Issued / Original Publication Date: 2021-12-08
Updated Date: 2021-12-17
Summary Safety Review - Contact Lenses - Assessing the Potential Risk of Limbal Stem Cell Deficiency
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00274
Issued / Original Publication Date: 2021-09-24
Summary Safety Review - Gadolinium-Based Contrast Agents - Assessing the Potential Risks of Congenital Anomalies, Stillbirth and Neonatal Death
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00273
Issued / Original Publication Date: 2021-09-22
Summary Safety Review - Systemic and Inhaled Fluoroquinolone Antibiotics - Assessing the Potential Risk of Heart Valve Regurgitation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00272
Issued / Original Publication Date: 2021-08-27
Summary Safety Review - Veklury (remdesivir) - Assessing the Potential Risk of Sinus Bradycardia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00271
Issued / Original Publication Date: 2021-08-18
Summary Safety Review - Kadcyla (trastuzumab emtansine) - Assessing the Potential Risk of Tumor Lysis Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00270
Issued / Original Publication Date: 2021-06-24
Summary Safety Review - Dopamine Agonists - Assessing the Potential Risk of Dopamine Agonist Withdrawal Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00269
Issued / Original Publication Date: 2021-06-08
Summary Safety Review - Pomalyst (pomalidomide) and Thalomid (thalidomide) - Assessing the Potential Risk of Progressive Multifocal Leukoencephalopathy
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00268
Issued / Original Publication Date: 2021-05-27

Displaying 41 - 50 of 292 | Page 5 of 30
Report a problem or mistake on this page
Please select all that apply:
Date modified: